Keynote | Corinne Le Goff, PharmD, MBA

Saturday January 29th, 3:30 PM - 4:30 PM CT

Corinne Le Goff served as Chief Commercial Officer of Moderna until the end of 2021. In that role, she led Moderna’s long term global commercial strategy and was responsible for developing a global presence and the key capabilities needed to ensure the timely distribution of the COVID-19 vaccine in countries and regions around the world.

Dr. Le Goff joined Moderna from Amgen, where she served as SVP and President of the US Business driving the growth strategy with increased contributions from Repatha® and Aimovig®. During her nearly 6-year tenure at Amgen, she also served as SVP of the Europe Region and oversaw 48 markets. Dr. Le Goff was actively engaged with the policy community and advocates for innovative, high-quality and affordable healthcare. She represented Amgen as a member of the Healthcare Leadership Council.

Prior to joining Amgen, Dr. Le Goff held a number of senior international roles at Roche, including President of Roche France, a major affiliate of the Roche Group, and Global Product Strategy Head of Neuroscience & Rare Diseases. Early in her career, Dr. Le Goff spent 11 years in various leadership roles at Sanofi and Pfizer in the Unites States.

Dr. Le Goff is a Director of Longboard Pharmaceuticals since February 2021. She also served on the Board of Directors of CFAO, a trading company that operates in Africa, for 6 years until December 2020. Dr. Le Goff received a Doctorate in Pharmacy from Rene Descartes University in Paris and a Master of Business Administration from La Sorbonne University and INSEAD. She also holds a US patent. She has recently been recognized by Forbes Magazine as one of the women over the age of 50 who are changing the world.